98%
921
2 minutes
20
Background: We present a case of severe gastroparesis with pyloric spasm secondary to radiofrequency catheter ablation (RFCA) with a focus on procedural risk factors, prevention, and treatment modalities.
Case Report: A 39-year-old man with paroxysmal atrial fibrillation underwent RFCA after failed pharmaceutical treatment. The procedure involved three-dimensional mapping and controlled RFCA near the oesophagus. Post-procedure, he developed severe abdominal pain, distention, and vomiting. Imaging revealed stomach distention and pyloric spasm. An upper endoscopy confirmed gastroparesis due to ablation. Metoclopramide was administered, improving food tolerance. However, persistent symptoms led to a gastric emptying study showing delayed emptying, consistent with gastroparesis. Despite treatment with metoclopramide, the patient's symptoms persisted, prompting consideration of esophageal botulinum toxin and medication changes for symptom management.
Conclusions: In a patient with no prior history of abdominal symptoms or chronic gastric disorder post ablation presentation of new-onset abdominal distention, pain, and vomiting ablation-induced gastroparesis should be high on the differential and different treatment modalities should be tried if severe symptoms such as postprandial regurgitation persist. Moreover, better oesophageal protection strategies should be implemented, and guidelines be added to procedure performance limiting excessive force, energy, manipulation, and introduction of oesophageal temperature control holding parameters.
Learning Points: Gastroparesis can be an under-recognized complication of left atrial ablation.Posterior wall ablation near the oesophagus is high-risk for gastrointestinal complications.Symptoms usually persist for 3-6 months but may last long term.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12331283 | PMC |
http://dx.doi.org/10.12890/2025_005596 | DOI Listing |
JAMA Netw Open
September 2025
City St George's, University of London, London, UK.
JAMA Netw Open
September 2025
Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock.
Importance: Patients with kidney failure (KF) receiving long-term dialysis have increased incidence of atrial fibrillation (AF). Patients with KF and AF have increased risk of stroke, death, and bleeding compared with age-matched cohorts. In KF, the use of oral anticoagulants (OACs) increases hemorrhage risk, offsetting potential benefits and making left atrial appendage occlusion (LAAO) a potentially promising solution for risk reduction in AF.
View Article and Find Full Text PDFEur J Prev Cardiol
September 2025
Department of Cardiology, Esbjerg and Grindsted Hospital - University Hospital of Southern Denmark, Esbjerg, Denmark.
Aim: This study aimed to establish general consensus on a systematic needs assessment model to determine eligibility for cardiac rehabilitation (CR) as part of secondary prevention in individuals with atrial fibrillation (AF). Specific objectives included identifying relevant needs assessment criteria and establishing consensus on referral criteria.
Methods: A Delphi study was conducted following the ACCORD guidelines (ACcurate COnsensus Reporting Document) with participation of an international, multi-disciplinary expert panel including physicians, nurses and other healthcare professionals, across primary and secondary care as well as academic research.
Int J Pharm Pract
September 2025
Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Suthep Road, Suthep, Mueang, Chiang Mai 50200, Thailand.
Objectives: Proton pump inhibitors (PPIs) are commonly used among these patients to prevent upper gastrointestinal bleeding (UGIB) in anticoagulated patients. However, their clinical benefits among patients receiving OACs with a history of UGIB remain inconclusive. This study aimed to summarize the clinical benefits of PPIs for the secondary prevention of recurrent UGIB among patients using OACs.
View Article and Find Full Text PDFJACC Case Rep
September 2025
Division of Academic Affairs and Research, Orlando Regional Medical Center, Orlando, Florida, USA. Electronic address:
Background: Tachycardia-induced cardiomyopathy (TICM) is typically reversible with rhythm control, but individual susceptibility remains poorly understood and may reflect genetic predisposition.
Case Summary: A 66-year-old woman with paroxysmal atrial fibrillation (AF) presented with new-onset heart failure. Genetic testing identified a likely pathogenic heterozygous ABCC9 gene variant (c.